Search results for: Value-Based Pricing
Filter search results
OHE at Priorities 2016: Valuing Health at the End of Life and MCDA for Priority Setting
19 September 2016
…discrete choice experiment. Social Science & Medicine, 124, pp.48-56. Shah, K.K., 2016. Does society place special value on end of life treatments? In: Round, J. ed. Care at the end of…
Valuing Vaccines: The Economics of Vaccines & Immunisations
26 April 2023, 3:00pm
…African policymakers and immunisation managers to assess the costs, consequences and value for money of vaccines through economic evaluation and make evidence–based decisions around national immunisation programmes. Access the modules…
New Publication: Important Aspects of Health Not Captured by EQ-5D
15 December 2016
…M.F., Longworth, L. and Ibbotson, R., 2016. Valuing health using time trade-off and discrete choice experiment methods: does dimension order impact on health state values? Value in Health, 19, pp.210-217….
25 Years of the Cost Effectiveness Acceptability Curve
30 December 2019
…meaningful way – with the uncertainty inherent in cost-effectiveness calculations. Uncertainty means decision makers may make wrong decisions – adopt a technology which turns out not to be good value…
Chronic Diseases and the Stock of Health: Quantification Using EQ-5D-5L
15 October 2019
…Feng, Y., Devlin, N., Bateman, A., Zamora, B. and Parkin, D., 2019. Distribution of the EQ-5D-5L Profiles and Values in Three Patient Groups. Value in Health, 22(3), pp.355–361. DOI. RePEc….
Adult Versus Adolescent Preferences for EQ-5D-Y Health States
15 April 2019
…to generate values for the EQ-5D-Y, a preference-based measure of health outcomes developed for children and adolescents aged between 8 and 15 years. Koonal focused in particular on a study…
Review of CRA’s Report “Assessing the Economic Impacts of Changing Exemption Provisions During Patent and SPC Protection in Europe”
1 January 2018
…this. The correct industrial strategy for the EU may well be to focus on the development, manufacture and export of innovative products, rather than on lower value generics where EU…
Health Technology Assessment of Gene Therapies: Are Our Methods Fit for Purpose?
1 June 2022
…use of conventional health technology assessment (HTA) approaches. Furthermore, current HTA methods may not fully capture the potential broader value of gene therapies, such as decreased burden on the patient…
Adding a “Cognition Bolt-on” to EQ-5D-5L: Insights from New Research and What’s Next
10 April 2025
…for consistent interpretation by both respondents and proxies. Where might a cognition bolt-on add value? While dementia is the most obvious condition where cognitive function is relevant, there are many…